Scientists search for inflammation clues in rare muscle disease
NCT ID NCT04694456
Summary
This completed pilot study aimed to understand how the immune system might contribute to facioscapulumeral muscular dystrophy type 1 (FSHD1), a genetic muscle-wasting disease. Researchers compared blood inflammation markers in 20 adults with FSHD1 to healthy people to see if specific immune signals were different. The goal was to gather basic knowledge about the disease process, not to test a treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCULAR DYSTROPHIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de NICE
Nice, France
Conditions
Explore the condition pages connected to this study.